Manufacture

Sitting Down With... Stephen Tindal, Director, Science & Technology at Catalent Pharma Solutions, to discuss his career in troubleshooting.

As the industry's reliance on CDMOs increases, how can the sector adapt to meet companies' needs?

How can manufacturing be improved for viral vectors?

How can we ensure we are better prepared to develop new vaccines and treatments for future infectious disease outbreaks?

Claudia Zylberberg explains the importance of ancillary material quality for advancing cell and gene therapies.

A new polio vaccine could help eradicate the disease once and for all.

How are industry and academia collaborating to tackle neglected diseases?

The world’s largest cell and gene CDMO, an exciting new TCR, and the global CAR T picture… We examine what’s going on in advanced medicine.

Gene therapies (including CAR T) could add $45 billion to US healthcare costs over the next five years, a CVS health report finds.

Researcher at the Wyss Institute have developed a biomaterial-based vaccine that reportedly eliminates acute myeloid leukemia.